digital-business-models-in-healthcare-book-matthias-puls.png

Andrea Mantovani

How Digital Solutions Can Leverage Pharma and Medtech

Rising therapeutic complexity, tighter economics, and patient expectations for personalization are reshaping life sciences. As AI, data, and connected devices converge, discovery accelerates, manufacturing becomes smarter, and care extends beyond the clinic—turning pipelines into platforms and interactions into outcomes.

Pre-order the book

AI, big data, and IoT are enabling a shift from reactive, episodic care to proactive, predictive, and personalized health—while rewiring R&D, manufacturing, and patient engagement end to end.

Digital transformation in pharma and medtech is no longer a side project. In discovery, machine learning screens libraries in silico, predicts binding, and cuts cycle times; in development, real-world evidence reshapes trials, improves enrollment, and safeguards patients. On the shop floor, sensorized “smart factories,” digital twins, and traceable batch records raise quality and resilience, while secure supply chains fight counterfeits and reduce waste. At the edge of care, telemedicine, RPM, and companion apps improve adherence and close gaps—provided integration, privacy, and proof of benefit are designed in from the start. What separates pilots from progress is a disciplined build of data, platforms, and talent that can scale across functions and markets.

When Convergence Becomes Capability:
From Experiments to Scalable Practice

What you’ll learn

How AI/ML is transforming R&D—from virtual screening and molecular modeling to faster enrollment and safer trials
How digital twins, sensorized manufacturing, and blockchain-enabled traceability strengthen quality, compliance, and supply chains
How telehealth, RPM, wearables, PROs, and RWE elevate engagement, adherence, and personalization at scale
Which hurdles matter most—regulation, data security, EHR integration, behavior change—and how leaders close the digital maturity gap
Where the field is heading next: expanding digital therapeutics, platform partnerships, and omnichannel, hyper-personalized engagement

Andrea Mantovani is a Senior Partner at Alira Health, leading global integrated consulting solutions with a focus on value, access, pricing, and go-to-market strategies across Pharma, biotech, and MedTech. With over 27 years of interna- tional consulting and industry experience – including senior roles at Accenture, Sanofi, and Novartis – Andrea specializes in oncology, hematology, cardiometabolic diseases, immunology, and rare diseases. His expertise blends strategic leadership, patient-centric methodologies, and data-driven insights. Andrea holds a degree in Marketing and Economics from the University of Verona, an MBA in Healthcare and Pharmaceuticals from SDA Bocconi Business School and serves as a contract professor at LUISS Business School and the MAMAF Master at Pavia University.